Quality of life, fatigue, depression, attention deficits, and pain after childhood Langerhans cell histiocytosis
Abstract: Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia with variable clinical presentation, ranging from self-healing single lesions to multisystem, potentially fatal disease. Long-term consequences, including progressive central nervous system (CNS) neurodegeneration, ar...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Blood Neoplasia |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950328025000330 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849423221523218432 |
|---|---|
| author | Malin Sveijer Désirée Gavhed Helena Hertzberg Eric Zander Jan-Inge Henter Tatiana von Bahr Greenwood |
| author_facet | Malin Sveijer Désirée Gavhed Helena Hertzberg Eric Zander Jan-Inge Henter Tatiana von Bahr Greenwood |
| author_sort | Malin Sveijer |
| collection | DOAJ |
| description | Abstract: Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia with variable clinical presentation, ranging from self-healing single lesions to multisystem, potentially fatal disease. Long-term consequences, including progressive central nervous system (CNS) neurodegeneration, are common. In this cross-sectional postal survey, we investigated how LCH affects long-term everyday life. All individuals aged ≥10 years diagnosed with LCH in childhood ≥5 years ago in Stockholm from 1990 to 2014 were invited to participate. Thirty-two of 61 eligible individuals (52%) answered questionnaires assessing health-related quality of life (HRQOL), fatigue, pain, depression, and attention deficits. Their median postdiagnosis time was 19.4 years. Overall, 14 of 32 (44%) had had multisystem disease, including 4 (12%) with risk organ involvement, and 17 of 32 (53%) had received systemic treatment. Five (16%) had CNS involvement, all with neurodegeneration. The mean total HRQOL score was 78.8 and the mean total fatigue score 68.7 (Pediatric Quality of Life Inventory). Five (16%) reported a diagnosed neurodevelopmental disorder. In patients aged ≥15 years, 42% reported long-lasting pain, and 27% had scores indicating depression. Poorer HRQOL correlated with fatigue and symptoms of depression and attention deficits. Patients with single-system disease and patients with multisystem disease with the longest duration of systemic treatment reported the best HRQOL. We conclude that patients with childhood LCH report high frequencies of fatigue, long-lasting pain, and symptoms of depression and attention deficit in the long term, which are associated with poorer quality of life and should be evaluated at follow-up. We also raise the question of whether longer treatment may reduce long-term consequences and have a positive impact on perceived quality of life. |
| format | Article |
| id | doaj-art-00b2d6ff636e4093b975fe22f5c4a8b6 |
| institution | Kabale University |
| issn | 2950-3280 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Blood Neoplasia |
| spelling | doaj-art-00b2d6ff636e4093b975fe22f5c4a8b62025-08-20T03:30:44ZengElsevierBlood Neoplasia2950-32802025-08-012310009810.1016/j.bneo.2025.100098Quality of life, fatigue, depression, attention deficits, and pain after childhood Langerhans cell histiocytosisMalin Sveijer0Désirée Gavhed1Helena Hertzberg2Eric Zander3Jan-Inge Henter4Tatiana von Bahr Greenwood5Childhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden; Department of Pediatrics, Eskilstuna Hospital, Eskilstuna, Sweden; Centre for Clinical Research Sörmland, Uppsala University, Uppsala, SwedenChildhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden; Division of Pediatric Oncology, Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, SwedenChildhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden; BB S:t Göran, Capio S:t Göran Hospital, Stockholm, SwedenCenter of Neurodevelopmental Disorders, Department of Women's and Children's Health, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, SwedenChildhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden; Division of Pediatric Oncology, Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden; Jan-Inge Henter, Department of Women’s and Children’s Health, Karolinska Institutet, Tomtebodavägen 18A, SE-171 77 Stockholm, Sweden;Childhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden; Division of Pediatric Oncology, Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden; Correspondence: Tatiana von Bahr Greenwood, Department of Women’s and Children’s Health, Karolinska Institutet, Tomtebodavägen 18A, SE-171 77 Stockholm, Sweden;Abstract: Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia with variable clinical presentation, ranging from self-healing single lesions to multisystem, potentially fatal disease. Long-term consequences, including progressive central nervous system (CNS) neurodegeneration, are common. In this cross-sectional postal survey, we investigated how LCH affects long-term everyday life. All individuals aged ≥10 years diagnosed with LCH in childhood ≥5 years ago in Stockholm from 1990 to 2014 were invited to participate. Thirty-two of 61 eligible individuals (52%) answered questionnaires assessing health-related quality of life (HRQOL), fatigue, pain, depression, and attention deficits. Their median postdiagnosis time was 19.4 years. Overall, 14 of 32 (44%) had had multisystem disease, including 4 (12%) with risk organ involvement, and 17 of 32 (53%) had received systemic treatment. Five (16%) had CNS involvement, all with neurodegeneration. The mean total HRQOL score was 78.8 and the mean total fatigue score 68.7 (Pediatric Quality of Life Inventory). Five (16%) reported a diagnosed neurodevelopmental disorder. In patients aged ≥15 years, 42% reported long-lasting pain, and 27% had scores indicating depression. Poorer HRQOL correlated with fatigue and symptoms of depression and attention deficits. Patients with single-system disease and patients with multisystem disease with the longest duration of systemic treatment reported the best HRQOL. We conclude that patients with childhood LCH report high frequencies of fatigue, long-lasting pain, and symptoms of depression and attention deficit in the long term, which are associated with poorer quality of life and should be evaluated at follow-up. We also raise the question of whether longer treatment may reduce long-term consequences and have a positive impact on perceived quality of life.http://www.sciencedirect.com/science/article/pii/S2950328025000330 |
| spellingShingle | Malin Sveijer Désirée Gavhed Helena Hertzberg Eric Zander Jan-Inge Henter Tatiana von Bahr Greenwood Quality of life, fatigue, depression, attention deficits, and pain after childhood Langerhans cell histiocytosis Blood Neoplasia |
| title | Quality of life, fatigue, depression, attention deficits, and pain after childhood Langerhans cell histiocytosis |
| title_full | Quality of life, fatigue, depression, attention deficits, and pain after childhood Langerhans cell histiocytosis |
| title_fullStr | Quality of life, fatigue, depression, attention deficits, and pain after childhood Langerhans cell histiocytosis |
| title_full_unstemmed | Quality of life, fatigue, depression, attention deficits, and pain after childhood Langerhans cell histiocytosis |
| title_short | Quality of life, fatigue, depression, attention deficits, and pain after childhood Langerhans cell histiocytosis |
| title_sort | quality of life fatigue depression attention deficits and pain after childhood langerhans cell histiocytosis |
| url | http://www.sciencedirect.com/science/article/pii/S2950328025000330 |
| work_keys_str_mv | AT malinsveijer qualityoflifefatiguedepressionattentiondeficitsandpainafterchildhoodlangerhanscellhistiocytosis AT desireegavhed qualityoflifefatiguedepressionattentiondeficitsandpainafterchildhoodlangerhanscellhistiocytosis AT helenahertzberg qualityoflifefatiguedepressionattentiondeficitsandpainafterchildhoodlangerhanscellhistiocytosis AT ericzander qualityoflifefatiguedepressionattentiondeficitsandpainafterchildhoodlangerhanscellhistiocytosis AT janingehenter qualityoflifefatiguedepressionattentiondeficitsandpainafterchildhoodlangerhanscellhistiocytosis AT tatianavonbahrgreenwood qualityoflifefatiguedepressionattentiondeficitsandpainafterchildhoodlangerhanscellhistiocytosis |